“…Furthermore, based on its low toxicity, high bioavailability (near to 100%), and the therapeutic effect equal to or better than other chloramphenicol analogs, FF is recommended to treat for intestinal tract and respiratory infectious diseases in livestock (Kim et al., ; Liu, Fung, Chen, Zeng, & Zhang, ; Ueda, Ohtsuki, & Narukawa, ). There are several previously published reports on the pharmacokinetics (PK) and pharmacodynamics (PD) of FF in the serum in vitro in the chicken, pigs, dogs, and so on (Burch & Klein, ; Dorey, Pelligand, Cheng, & Lees, ; Haritova & Fink‐Gremmels, ; Koc et al., ; Lei, Liu, Qi, et al., ; Lei, Liu, Yang, Ahmed, et al., ; Lei, Liu, Yang, Yang, et al., ; Lei, Liu, Zhu, et al., ; Maaland, Mo, Schwarz, & Guardabassi, ; Poźniak et al., ; Sidhu, Illambas, Potter, Rycroft, & Lees, ; Wang et al., ). However, it is insufficient to assay the practical effect and predict the dosage accordingly with serum and in vitro PK‐PD data.…”